Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Drug studies boost Vivus, Orexigen
By: MarketWatch
Posted on April 04, 2011 at 11:38 AM EDT
Shares of Vivus and Orexigen Therapeutics are climbing on the release of favorable studies for their respective diet-drugs, both of which are up for FDA approval.
Read More >>
Related Stocks:
AASTROM BIOSCIENCES DFM BANK IND Orexigen Therapeutics, Inc. Vivus, Inc.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here